From: Assessment of the in vitro acaricidal activity of Bravecto® (fluralaner) and a proposed orange oil-based formulation vehicle for the treatment of Sarcoptes scabiei
Test solution
Concentration
n
Median survival time (min)
Orange Power
10%
10
5
Bravecto (fluralaner)
20 mg/ml
25
Cydectin (moxidectin)
50 µg/ml
100
20
Mineral oil (negative control)
> 120